tiprankstipranks
Trending News
More News >
ENDRA Life Sciences Inc (NDRA)
NASDAQ:NDRA
US Market

ENDRA Life Sciences (NDRA) Ratios

Compare
792 Followers

ENDRA Life Sciences Ratios

NDRA's free cash flow for Q3 2024 was $0.00. For the 2024 fiscal year, NDRA's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 23Dec 22Dec 21Dec 20
Liquidity Ratios
Current Ratio
3.36 5.00 7.83 8.32 3.15
Quick Ratio
3.36 3.45 7.00 7.73 3.10
Cash Ratio
3.14 2.87 6.13 7.33 2.98
Solvency Ratio
-8.93 -6.27 -5.25 -7.40 -6.39
Operating Cash Flow Ratio
-10.57 -7.49 -7.20 -10.92 -4.14
Short-Term Operating Cash Flow Coverage
-335.23 -448.30 -84.05 -140.83 -23.58
Net Current Asset Value
$ 1.94M$ 6.46M$ 10.00M$ 6.62M$ 4.12M
Leverage Ratios
Debt-to-Assets Ratio
0.06 0.06 0.05 0.08 0.10
Debt-to-Equity Ratio
0.07 0.08 0.06 0.10 0.15
Debt-to-Capital Ratio
0.07 0.07 0.06 0.09 0.13
Long-Term Debt-to-Capital Ratio
0.00 0.00 <0.01 0.04 0.00
Financial Leverage Ratio
1.19 1.29 1.19 1.22 1.51
Debt Service Coverage Ratio
-343.52 -259.24 -82.86 -37.45 -4.81
Interest Coverage Ratio
0.00 -611.04 0.00 -49.49 -4.60
Debt to Market Cap
<0.01 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
0.04 0.20 0.33 0.96 8.17
Net Debt to EBITDA
0.25 0.34 0.80 0.58 0.50
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%0.00%0.00%
EBIT Margin
0.00%0.00%0.00%0.00%0.00%
EBITDA Margin
0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin
0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Profit Margin
0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT
100.00%100.16%99.63%102.06%116.90%
EBT Per EBIT
95.62%100.16%97.68%101.94%122.71%
Return on Assets (ROA)
-148.95%-142.34%-86.91%-136.53%-216.75%
Return on Equity (ROE)
-177.77%-183.23%-103.76%-166.92%-326.73%
Return on Capital Employed (ROCE)
-179.81%-173.80%-101.48%-147.87%-212.47%
Return on Invested Capital (ROIC)
-173.80%-170.03%-98.79%-148.00%-229.06%
Return on Tangible Assets
-148.95%-142.34%-86.91%-136.53%-216.75%
Earnings Yield
-0.03%-0.06%-0.02%-0.05%-0.07%
Efficiency Ratios
Receivables Turnover
0.00 0.00 0.00 0.00 0.00
Payables Turnover
0.76 0.38 0.28 0.41 0.09
Inventory Turnover
0.00 0.09 0.17 0.28 1.01
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00
Asset Turnover
0.00 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle
-477.57 3.16K 802.70 412.40 -3.70K
Days of Sales Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
0.00 4.12K 2.09K 1.30K 360.02
Days of Payables Outstanding
477.57 956.62 1.29K 889.94 4.06K
Operating Cycle
0.00 4.12K 2.09K 1.30K 360.02
Cash Flow Ratios
Operating Cash Flow Per Share
-1.06 -4.42 -5.44 -11.22 -22.90
Free Cash Flow Per Share
-1.06 -4.49 -5.46 -11.28 -23.02
CapEx Per Share
<0.01 0.07 0.02 0.05 0.12
Free Cash Flow to Operating Cash Flow
1.00 1.02 1.00 1.00 1.01
Dividend Paid and CapEx Coverage Ratio
-274.99 -60.70 -66.97 -24.10 -2.01
Capital Expenditure Coverage Ratio
-281.81 -63.03 -247.16 -209.82 -197.01
Operating Cash Flow Coverage Ratio
-24.21 -23.36 -16.38 -15.71 -12.15
Operating Cash Flow to Sales Ratio
0.00 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-0.03%-0.06%-0.02%-0.04%-0.04%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-3.33K -1.56K -4.43K -2.10K -1.42K
Price-to-Sales (P/S) Ratio
0.00 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
5.92K 2.86K 4.59K 3.51K 4.63K
Price-to-Free Cash Flow (P/FCF) Ratio
-3.50K -1.59K -4.44K -2.33K -2.55K
Price-to-Operating Cash Flow Ratio
-3.51K -1.61K -4.45K -2.34K -2.57K
Price-to-Earnings Growth (PEG) Ratio
44.02 94.81 78.87 30.10 306.72
Price-to-Fair Value
5.92K 2.86K 4.59K 3.51K 4.63K
Enterprise Value Multiple
-3.43K -1.59K -4.50K -2.22K -2.03K
EV to EBITDA
-3.43K -1.59K -4.50K -2.22K -2.03K
EV to Sales
0.00 0.00 0.00 0.00 0.00
EV to Free Cash Flow
-3.50K -1.59K -4.44K -2.33K -2.55K
EV to Operating Cash Flow
-3.51K -1.61K -4.45K -2.34K -2.57K
Tangible Book Value Per Share
0.63 2.49 5.27 7.47 12.70
Shareholders’ Equity Per Share
0.63 2.49 5.27 7.47 12.70
Tax and Other Ratios
Effective Tax Rate
0.00 >-0.01 <0.01 -0.02 -0.17
Revenue Per Share
0.00 0.00 0.00 0.00 0.00
Net Income Per Share
-1.11 -4.57 -5.47 -12.47 -41.48
Tax Burden
1.00 1.00 1.00 1.02 1.17
Interest Burden
1.00 1.00 1.00 1.02 1.22
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.95 0.97 0.99 0.92 0.65
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis